Advanced

Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.

Kurbasic, Emila LU ; Sjöström, Martin LU ; Krogh, Morten; Folkesson, Elin LU ; Grabau, Dorthe LU ; Hansson, Karin M; Rydén, Lisa LU ; Waldemarson, Sofia LU ; James, Peter LU and Niméus, Emma LU (2015) In Clinical Proteomics 12(1).
Abstract
Breast cancer is a very heterogeneous disease and some patients are cured by the surgical removal of the primary tumour whilst other patients suffer from metastasis and spreading of the disease, despite adjuvant therapy. A number of prognostic and treatment predictive factors have been identified such as tumour size, oestrogen (ER) and progesterone (PgR) receptor status, human epidermal growth factor receptor type 2 (HER2) status, histological grade, Ki67 and age. Lymph node involvement is also assessed during surgery to determine if the tumour has spread which requires dissection of the axilla and adjuvant treatment. The prognostic and treatment predictive factors assessing the nature of the tumour are all routinely based on the status of... (More)
Breast cancer is a very heterogeneous disease and some patients are cured by the surgical removal of the primary tumour whilst other patients suffer from metastasis and spreading of the disease, despite adjuvant therapy. A number of prognostic and treatment predictive factors have been identified such as tumour size, oestrogen (ER) and progesterone (PgR) receptor status, human epidermal growth factor receptor type 2 (HER2) status, histological grade, Ki67 and age. Lymph node involvement is also assessed during surgery to determine if the tumour has spread which requires dissection of the axilla and adjuvant treatment. The prognostic and treatment predictive factors assessing the nature of the tumour are all routinely based on the status of the primary tumour. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Clinical Proteomics
volume
12
issue
1
publisher
Humana Press
external identifiers
  • pmid:25991917
  • wos:000371208900001
  • scopus:84988734786
ISSN
1559-0275
DOI
10.1186/s12014-015-9084-7
project
CREATE Health
language
English
LU publication?
yes
id
f494490e-1768-4a13-aee8-bde9bbd65b35 (old id 5448566)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25991917?dopt=Abstract
date added to LUP
2015-06-05 11:07:44
date last changed
2017-09-24 04:36:56
@article{f494490e-1768-4a13-aee8-bde9bbd65b35,
  abstract     = {Breast cancer is a very heterogeneous disease and some patients are cured by the surgical removal of the primary tumour whilst other patients suffer from metastasis and spreading of the disease, despite adjuvant therapy. A number of prognostic and treatment predictive factors have been identified such as tumour size, oestrogen (ER) and progesterone (PgR) receptor status, human epidermal growth factor receptor type 2 (HER2) status, histological grade, Ki67 and age. Lymph node involvement is also assessed during surgery to determine if the tumour has spread which requires dissection of the axilla and adjuvant treatment. The prognostic and treatment predictive factors assessing the nature of the tumour are all routinely based on the status of the primary tumour.},
  articleno    = {13},
  author       = {Kurbasic, Emila and Sjöström, Martin and Krogh, Morten and Folkesson, Elin and Grabau, Dorthe and Hansson, Karin M and Rydén, Lisa and Waldemarson, Sofia and James, Peter and Niméus, Emma},
  issn         = {1559-0275},
  language     = {eng},
  number       = {1},
  publisher    = {Humana Press},
  series       = {Clinical Proteomics},
  title        = {Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.},
  url          = {http://dx.doi.org/10.1186/s12014-015-9084-7},
  volume       = {12},
  year         = {2015},
}